An open trial of paroxetine in the treatment of children and adolescents diagnosed with dysthymia

Maria Nobile, Barbara Bellotti, Cecilia Marino, Massimo Molteni, Marco Battaglia

Research output: Contribution to journalArticle

Abstract

This open-label study examined the potential efficacy of paroxetine in the treatment of children and adolescents diagnosed with dysthymia over a period of 3 months. Seven subjects were evaluated by the Hamilton Depression Rating Scale (HAM-D), by the Clinical Global Impression Severity of Illness Scale (CGI-S), and the Clinical Global Impression Improvement Scale (CGI-I). Seventy-one percent of patients had a satisfactory response, suggesting the efficacy of paroxetine in children with dysthymia.

Original languageEnglish
Pages (from-to)103-109
Number of pages7
JournalJournal of Child and Adolescent Psychopharmacology
Volume10
Issue number2
Publication statusPublished - Jun 2000

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'An open trial of paroxetine in the treatment of children and adolescents diagnosed with dysthymia'. Together they form a unique fingerprint.

  • Cite this